| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | IDEXX LABORATORIES CMN | Sep 25, 2026 | |
| Sell | IDEXX LABORATORIES CMN | Sep 11, 2026 | |
| Sell | IDEXX LABORATORIES CMN | Sep 4, 2026 | |
| Sell | IDEXX LABORATORIES CMN | Aug 3, 2026 | |
| Sell | IDEXX LABORATORIES CMN | Jun 30, 2026 | |
| Buy | IDEXX LABORATORIES INC. CMN | Feb 17, 2026 | |
| Sell | IDEXX Laboratories, Inc. | Jan 13, 2026 | |
| Sell | IDEXX Laboratories, Inc. | Dec 2, 2025 | |
| Sell | IDEXX Laboratories, Inc. | Oct 29, 2025 | |
| Sell | IDEXX Laboratories, Inc. | Oct 16, 2025 |
This page tracks congressional stock trading activity in IDEXX Laboratories, Inc. (IDXX) in the Healthcare sector. Disclosed Capitol has indexed 101 disclosed congressional trades involving IDXX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of October 2026 — Disclosed Capitol has tracked 101 disclosed congressional trades in IDEXX Laboratories, Inc. (IDXX) — 58:39 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Sep 25, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Sep 11, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Sep 4, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Aug 3, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jun 30, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Feb 17, 2026 | Ro Khanna | D | Buy | $15,001 - $50,000 |
| Jan 13, 2026 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
| Dec 2, 2025 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
| Oct 29, 2025 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
| Oct 16, 2025 | April McClain Delaney | D | Sell | $1,001 - $15,000 |
Across the 101 disclosed congressional trades in IDEXX Laboratories, Inc. (IDXX), members of Congress have reported 58 buys and 39 sells. The average 30-day alpha vs. the S&P 500 is -0.55%.
As of September 2026, IDEXX Laboratories, Inc. has 27 federal contract award records on file from USAspending.gov — most recently $32K from the Department of Health and Human Services on 2026-09-14.
| Award date | Agency | Amount |
|---|---|---|
| 2026-09-14 | Department of Health and Human Services · Food and Drug Administration | $32K |
| 2026-08-12 | Environmental Protection Agency | $51K |
| 2026-08-12 | Environmental Protection Agency | $51K |
| 2025-12-17 | Department of Defense · Department of the Army | $92K |
| 2025-09-23 | Department of Agriculture · Agricultural Research Service | $111K |
| 2025-09-03 | Department of Defense · Department of the Army | $57K |
| 2025-02-03 | Department of Defense · Department of the Army | $87K |
| 2024-09-12 | Department of Defense · Department of the Army | $139K |
| 2024-09-05 | Department of Defense · Department of the Navy | $95K |
| 2024-02-05 | Department of Defense · Department of the Army | $82K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, IDEXX Laboratories, Inc. reported revenue of $4.30B and net income of $1.06B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $2.36B, net income $616.9M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.